Stealth-mode venture-funded company. Discovering and developing oral novel small molecule inhibitors for treating neurodegenerative and cardiometabolic diseases.
University of North Carolina, Raleigh Street, Franklin-Rosemary Historic District, Baby Hollow, Chapel Hill, Orange County, North Carolina, 27599, United States
